Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells

被引：0
|
作者：
J Kraan
P van den Broek
C Verhoef
D J Grunhagen
W Taal
J W Gratama
S Sleijfer
机构：
[1] Erasmus MC Cancer Institute,Department of Medical Oncology
[2] Erasmus MC Cancer Institute,Department of Surgical Oncology
[3] Erasmus MC Cancer Institute,Department of Neuro
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
circulating endothelial cells (CEC); tumour endothelial markers (TEM); CD276; pericytes; endothelial cells; flowytometry; rare events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：149 / 156
页数：7
相关论文
共 50 条
  • [1] Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
    Kraan, J.
    van den Broek, P.
    Verhoef, C.
    Grunhagen, D. J.
    Taal, W.
    Gratama, J. W.
    Sleijfer, S.
    BRITISH JOURNAL OF CANCER, 2014, 111 (01) : 149 - 156
  • [2] Pan-cancer associations of B7-H3 (CD276) transcriptional expression across human malignancies
    Hwang, Justin
    Zorko, Nick
    Elliott, Andrew
    Lozada, Jose A.
    Radovich, Milan
    Heath, Elisabeth I.
    Agarwal, Neeraj
    McKay, Rana R.
    Garje, Rohan
    Bastos, Bruno R.
    Hoon, Dave S. B.
    Nabhan, Chadi
    Sledge, George W.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells
    Son, YeonSung
    Kwon, Sang-Mo
    Cho, Je-Yoel
    STEM CELLS, 2019, 37 (03) : 382 - 394
  • [4] Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
    Inamura, Kentaro
    Takazawa, Yutaka
    Inoue, Yosuke
    Yokouchi, Yusuke
    Kobayashi, Maki
    Saiura, Akio
    Shibutani, Tomoko
    Ishikawa, Yuichi
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (07)
  • [5] B7-H3/CD276: An Emerging Cancer Immunotherapy
    Zhou, Wu-Tong
    Jin, Wei-Lin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
    Liang, Jiayu
    Liu, Zhihong
    Pei, Tianjiao
    Xiao, Yingming
    Zhou, Liang
    Tang, Yongquan
    Zhou, Chuan
    Wu, Kan
    Zhang, Fuxun
    Zhang, Fan
    Yin, Xiaoxue
    Chen, Ni
    Wei, Xin
    Lu, Yiping
    Zhu, Yuchun
    DISEASE MARKERS, 2020, 2020
  • [7] Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meninninma
    Deng, Jiaojiao
    Ma, Mengyin
    Wang, Daijun
    Zhu, Hongda
    Hua, Lingyang
    Sun, Shuchen
    Chen, Hong
    Cheng, Haixia
    Qian, Zhi Rong
    Xie, Qing
    Zhang, Tao
    Gong, Ye
    WORLD NEUROSURGERY, 2020, 135 : e12 - e18
  • [8] Tumor B7-H3 (CD276) expression and survival of patients with pancreatic cancer
    Inamura, Kentaro
    Yokouchi, Yusuke
    Kobayashi, Maki
    Inoue, Yosuke
    Saiura, Akio
    Takazawa, Yutaka
    Ishikawa, Yuichi
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
    Picarda, Elodie
    Ohaegbulam, Kim C.
    Zang, Xingxing
    CLINICAL CANCER RESEARCH, 2016, 22 (14) : 3425 - 3431
  • [10] Stimulation of B7-H3 (CD276) directs the differentiation of human marrow stromal cells to osteoblasts
    Xu, Lan
    Zhang, Guangbo
    Zhou, Yinghui
    Chen, Yongjing
    Xu, Wei
    Wu, Shiliang
    Zhang, Xueguang
    IMMUNOBIOLOGY, 2011, 216 (12) : 1311 - 1317
12345